Cancer Biotherapy and Radiopharmaceuticals · 2005 · 34 citations · 29 references
PharmacyMolecular BiologyOncologyAntibody EngineeringMolecular OncologyMonoclonal AntibodiesAntibody CharacterizationAntibody DiscoveryAntibody Library ConstructionMonoclonal Antibody TechnologyMonoclonal Antibody TherapyTherapeutic Antibody DevelopmentAntibody Library DesignExtracellular DomainsHuman Antibody LibrariesMonoclonal Antibodies In CancerMonoclonal Antibody SelectionPhage Display LibrariesPhage LibrariesSingle-domain Antibody Libraries
The members of the epidermal growth factor receptor (EGFR) family are over expressed in a variety of malignancies and are frequently linked to aggressive disease and a poor prognosis. Although clinically effective monoclonal antibodies (MAbs) have been developed to target HER2 and EGFR, the remaining two family members, HER3 and HER4, have not been the subject of significant efforts. In this paper, we have taken the initial steps required to generate antibodies with potential clinically utility that target the members of the EGFR family. The genes for the extracellular domains (ECDs) of all four members of the EGFR family were cloned and used to stably transfect 293 (HEK) cells. Milligram quantities of each ECD were produced and characterized. The HER3, HER4, and EGFR ECDs were then employed as targets for the selection of antibodies from naïve human scFv (single-chain Fv) phage display libraries. Six unique scFv clones were isolated that bound specifically to HER3, 13 unique clones were isolated with specificity for HER4 and 52 unique anti-EGFR clones were isolated. These scFvs provide a valuable and potentially clinically relevant panel of agents to target the members of the EGFR family.
29
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
A small molecule–kinase interaction map for clinical kinase inhibitors
Miles A. Fabian, William Biggs, Daniel K. Treiber et al. · Nature Biotechnology · 2005 · 1.9K citations · Full text
James D. Marks, Hennie R. Hoogenboom, Timothy P. Bonnert et al. · Journal of Molecular Biology · 1991 · 1.6K citations
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Matthew C. Franklin, Kendall D. Carey, F.F. Vajdos et al. · Cancer Cell · 2004 · 1.1K citations · Full text